Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Haruhiko Morita2026-05-27 | 0.38% | -0.01pp |
| LSIM Inc.2026-05-27 | 5.02% | -0.21pp |
| Haruhiko Morita2026-05-01 | 0.39% | -0.08pp |
| LSIM Inc.2026-05-01 | 5.23% | -1.05pp |
| Haruhiko Morita2025-10-16 | 0.47% | no change |
| LSIM Inc.2025-10-16 | 6.28% | new |
| Evolution Capital Management LLC2025-09-05 · amended | 0.00% | no change |
| Evo Fund2025-09-05 · amended | 21.88% | +17.88pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 4.00% | -1.07pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 5.07% | -1.00pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 6.07% | -1.34pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 7.41% | -1.29pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 8.70% | -1.62pp |
| Evolution Capital Management LLC2025-09-01 · amended | 0.00% | no change |
| Evo Fund2025-09-01 · amended | 10.32% | -1.04pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.